{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:06:50Z","timestamp":1791295610779,"version":"4.1.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2016,3]]},"abstract":"<jats:p>\n            Galectin-3 (Gal-3) is involved in inflammation, fibrogenesis, and cardiac remodeling. Previous evidence shows that Gal-3 interacts with aldosterone in promoting macrophage infiltration and vascular fibrosis and that Gal-3 genetic and pharmacological inhibition prevents remodeling in a pressure-overload animal model of heart failure. We aimed to explore the contribution of Gal-3 and aldosterone in mechanisms leading to heart failure in a murine model. Male mice with cardiac-specific hyperaldosteronism underwent isoproterenol subcutaneous injections, to be then randomized to receive placebo, a Gal-3 inhibitor (modified citrus pectin [MCP]), an aldosterone antagonist (potassium canrenoate), or MCP+canrenoate for 14 days. Isoproterenol induced a rapid and persistent decrease in left ventricular fractional shortening (\u221220% at day 14); this was markedly improved by treatment with either MCP or canrenoate (both\n            <jats:italic>P<\/jats:italic>\n            &lt;0.001 versus placebo). MCP and canrenoate also reduced cardiac hypertrophy and fibrosis and the expression of genes involved in fibrogenesis (\n            <jats:italic>Coll-1<\/jats:italic>\n            and\n            <jats:italic>Coll-3<\/jats:italic>\n            ) and macrophage infiltration (\n            <jats:italic>CD-68<\/jats:italic>\n            and\n            <jats:italic>MCP-1<\/jats:italic>\n            ). After isoproterenol, Gal-3 gene expression (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05 versus placebo) and protein levels (\u221261% and \u221269% versus placebo) were decreased by both canrenoate and MCP. The combined use of antagonists of Gal-3 and aldosterone resulted in more pronounced effects on cardiac hypertrophy, inflammation, and fibrosis, when compared with either MCP or canrenoate alone. Inhibition of Gal-3 and aldosterone can reverse isoproterenol-induced left ventricular dysfunction, by reducing myocardial inflammation and fibrogenesis. Gal-3 likely participates in mechanisms of aldosterone-mediated myocardial damage in a heart failure murine model with cardiac hyperaldosteronism. Gal-3 inhibition may represent a new promising therapeutic option in heart failure.\n          <\/jats:p>","DOI":"10.1161\/hypertensionaha.115.06161","type":"journal-article","created":{"date-parts":[[2016,1,19]],"date-time":"2016-01-19T02:42:54Z","timestamp":1453171374000},"page":"606-612","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":119,"title":["Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice"],"prefix":"10.1161","volume":"67","author":[{"given":"Giuseppe","family":"Vergaro","sequence":"first","affiliation":[{"name":"From INSERM U942 and Universit\u00e9 Paris-Diderot, Paris, France (G.V., M.P., L.F., R.M., J.-L.S., A.C.S., C.D.); Institute of Life Sciences, Scuola Superiore Sant\u2019Anna di Pisa, Pisa, Italy (G.V., C.P., M.E.); and Cardiology and Cardiovascular Medicine Division, Fondazione Toscana Gabriele Monasterio, Pisa, Italy (G.V., C.P., M.E.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Prud\u2019homme","sequence":"additional","affiliation":[{"name":"From INSERM U942 and Universit\u00e9 Paris-Diderot, Paris, France (G.V., M.P., L.F., R.M., J.-L.S., A.C.S., C.D.); Institute of Life Sciences, Scuola Superiore Sant\u2019Anna di Pisa, Pisa, Italy (G.V., C.P., M.E.); and Cardiology and Cardiovascular Medicine Division, Fondazione Toscana Gabriele Monasterio, Pisa, Italy (G.V., C.P., M.E.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loubina","family":"Fazal","sequence":"additional","affiliation":[{"name":"From INSERM U942 and Universit\u00e9 Paris-Diderot, Paris, France (G.V., M.P., L.F., R.M., J.-L.S., A.C.S., C.D.); Institute of Life Sciences, Scuola Superiore Sant\u2019Anna di Pisa, Pisa, Italy (G.V., C.P., M.E.); and Cardiology and Cardiovascular Medicine Division, Fondazione Toscana Gabriele Monasterio, Pisa, Italy (G.V., C.P., M.E.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regine","family":"Merval","sequence":"additional","affiliation":[{"name":"From INSERM U942 and Universit\u00e9 Paris-Diderot, Paris, France (G.V., M.P., L.F., R.M., J.-L.S., A.C.S., C.D.); Institute of Life Sciences, Scuola Superiore Sant\u2019Anna di Pisa, Pisa, Italy (G.V., C.P., M.E.); and Cardiology and Cardiovascular Medicine Division, Fondazione Toscana Gabriele Monasterio, Pisa, Italy (G.V., C.P., M.E.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Passino","sequence":"additional","affiliation":[{"name":"From INSERM U942 and Universit\u00e9 Paris-Diderot, Paris, France (G.V., M.P., L.F., R.M., J.-L.S., A.C.S., C.D.); Institute of Life Sciences, Scuola Superiore Sant\u2019Anna di Pisa, Pisa, Italy (G.V., C.P., M.E.); and Cardiology and Cardiovascular Medicine Division, Fondazione Toscana Gabriele Monasterio, Pisa, Italy (G.V., C.P., M.E.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Emdin","sequence":"additional","affiliation":[{"name":"From INSERM U942 and Universit\u00e9 Paris-Diderot, Paris, France (G.V., M.P., L.F., R.M., J.-L.S., A.C.S., C.D.); Institute of Life Sciences, Scuola Superiore Sant\u2019Anna di Pisa, Pisa, Italy (G.V., C.P., M.E.); and Cardiology and Cardiovascular Medicine Division, Fondazione Toscana Gabriele Monasterio, Pisa, Italy (G.V., C.P., M.E.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane-Lise","family":"Samuel","sequence":"additional","affiliation":[{"name":"From INSERM U942 and Universit\u00e9 Paris-Diderot, Paris, France (G.V., M.P., L.F., R.M., J.-L.S., A.C.S., C.D.); Institute of Life Sciences, Scuola Superiore Sant\u2019Anna di Pisa, Pisa, Italy (G.V., C.P., M.E.); and Cardiology and Cardiovascular Medicine Division, Fondazione Toscana Gabriele Monasterio, Pisa, Italy (G.V., C.P., M.E.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Cohen Solal","sequence":"additional","affiliation":[{"name":"From INSERM U942 and Universit\u00e9 Paris-Diderot, Paris, France (G.V., M.P., L.F., R.M., J.-L.S., A.C.S., C.D.); Institute of Life Sciences, Scuola Superiore Sant\u2019Anna di Pisa, Pisa, Italy (G.V., C.P., M.E.); and Cardiology and Cardiovascular Medicine Division, Fondazione Toscana Gabriele Monasterio, Pisa, Italy (G.V., C.P., M.E.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Delcayre","sequence":"additional","affiliation":[{"name":"From INSERM U942 and Universit\u00e9 Paris-Diderot, Paris, France (G.V., M.P., L.F., R.M., J.-L.S., A.C.S., C.D.); Institute of Life Sciences, Scuola Superiore Sant\u2019Anna di Pisa, Pisa, Italy (G.V., C.P., M.E.); and Cardiology and Cardiovascular Medicine Division, Fondazione Toscana Gabriele Monasterio, Pisa, Italy (G.V., C.P., M.E.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)31891-4"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0511167103"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2008.070726"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000147181.65298.4D"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.112.971168"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-5299.2000.80159.x"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfs105"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022214303001914"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1042\/CS20070123"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.190512"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.112.300569"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.08-106617"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018683"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2014.08.002"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000142858.44680.27"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.04.157"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01906668"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.67.6.1474"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)00557-7"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.2002.2088"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095254"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2014.07.015"},{"key":"e_1_3_3_24_2","first-page":"443","article-title":"An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat.","volume":"67","author":"Rona G","year":"1959","unstructured":"Rona G, Chappel CI, Balazs T, Gaudry R. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. AMA Arch Pathol. 1959;67:443\u2013455.","journal-title":"AMA Arch Pathol"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.75.1.105"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2828(85)80132-2"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2014.10.001"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.2174\/1389450033490948"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00017.2008"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2014.12.001"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0001-2815.2004.00278.x"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.000785"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.115.06161","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:26:36Z","timestamp":1715592396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.115.06161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.115.06161"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.115.06161","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"2015-12-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-12-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-01-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}